Rb function is required for E1A-induced S-phase checkpoint activation

Cell Death and Differentiation

Volumn 15, Issue 9, 2008, Pages 1440-1449

  Nemajerova, A ^a   Talos, F ^a   Moll, U M ^a   Petrenko, O ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; PROTEASOME; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; DNA REPLICATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CHROMATIN; DIPLOIDY; DNA DAMAGE; G1 PHASE; GENOMIC INSTABILITY; HUMANS; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOBLASTOMA PROTEIN; S PHASE;

EID: 49949091315     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.66     Document Type: Article

References (40)

1. Van der Eb AJ, Mulder C, Graham FL, Houweling A. Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene 1977; 2: 115-132.
2. Ruley HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 1983; 304: 602-606.
3. Matlashewski G, Schneider J, Banks L, Jones N, Murray A, Crawford L. Human papillomavirus type 16 DNA cooperates with activated ras in transforminq primary cells. EMBO J 1987; 6: 1741-1746.
4. Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell 1989; 56: 67-75.
5. Nevins JR. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424-429.
6. Frisch SM, Mymryk JS. Adenovirus-5 E1A: Paradox and paradigm. Nat Rev Mol Cell Biol 2002; 3: 441-452.
7. Bandara LR, La Thangue NB. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 1991, 351: 494-497.
8. Bagchi S, Weinmann R, Raychaudhuri P. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 1991; 65: 1063-1072.
9. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65: 1053-1061.
10. Cao L, Faha B, Dembski M, Tsai LH, Harlow E, Dyson N. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 1992; 355: 176-179.
11. Fattaey AR, Harlow E, Helin K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 1993; 13: 7267-7277.
12. Petrenko O, Moll UM. Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell 2005: 17: 225-236.
13. Mittnacht S, Weinberg RA. G1/S phosphorylation of the retinoblastoma protein is associated with an altered for the nuclear compartment. Cell 1991; 65: 381-393.
14. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000; 14: 3051-3064.
15. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B et al Targeted disruption of the three Rb-related leads to loss G(1) control and immortalization. Genes Dev 2000; 14: 3037-3050.
16. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 1998; 12: 2434-2442.
17. Gross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL et al. A p53-dependent mouse spindle checkpoint. Science 1995; 267: 1353-1356.
18. Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000; 14: 2393-2409.
19. Frolov MV, Dyson NJ. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 2004; 117: 2113-2181.
20. Isaac CE, Francis SM, Martens AL, Julian LM, Seifried LA, Erdmann N et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol 2006; 26: 3659-3671.
21. Sun H, Chang Y, Schweers B, Dyer MA, Zhang X, Hayward SW et al. An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol Cell Biol 2006; 26: 1527-1537.
22. Hofmann F, Martelli F, Livingston DM, Wang Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev 1996; 10: 2949-2959.
23. Campanero MR, Flemington EK. Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci USA 1997; 94: 2221-2226.
24. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 1996; 10: 2960-2970.
25. Nakajima T, Morita K, Tsunoda H, Imajoh-Ohmi S, Tanaka H, Yasuda H. et al. Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway. J Biol Chem 1998; 273: 20036-20045.
26. Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS et al. Regulation of the 26S proteasome by adenovirus E1A. EMBO J 2000; 19: 4759-4773.
27. Zhang X, Turnell AS, Gorbea C, Mymryk JS, Gallimore PH, Grand RJ. The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression. J Biol Chem 2004; 279: 25122-25133.
28. Samuelson AV, Lowe SW. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci USA 1997; 94: 12094-12099.
29. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-785.
30. Kanda T, Sullivan KF, Wahl GM. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 1998; 8: 377-385.
31. Ghosh MK, Harter ML. A viral mechanism for remodeling chromatin structure in GO cells. Mol Cell 2003; 12: 255-260.
32. Avni D, Yang H, Martelli F, Hofmann F, ElShamy WM, Ganesan S et al Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol Cell 2003; 12: 735-746.
33. Cam H, Dynlacht BD. Emerging roles for E2F: Beyond the G1/S transition and DNA replication. Cancer Cell 2003; 3: 311-316.
34. Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization of DNA replication in primary mammalian cells. Genes Dev 2000; 14: 2855-2868.
35. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 2005; 20: 801-809.
36. Peeper DS, Dannenberg JH, Douma S, te Riele H, Bernards R. Escape from premature senescence is not sufficient for oncogenic transformation by Ras. Nat Cell Biol 2001; 3: 198-203.
37. Rowland BD, Bernards R. Re-evaluating cell-cycle regulation by E2Fs. Cell 2006; 127: 871-874.
38. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 2000; 20: 5797-5807.
39. Mendez J, Stillman B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: Assembly of prereplication complexes in late mitosis Mol Cell Biol 2000; 20: 8602-8612.
40. Seifried LA, Talluri S, Cecchini M, Julian LM, Mymryk JS, Dick FA. pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption. J Virol 2008 (in press).